Novelion

NVLN-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about NVLN-T

Signal
Opinion
Expert
TOP PICK
TOP PICK
September 23, 2003
One trick pony however, they do have some tremendous potential for expansion of their Visodine product. Also expecting approval for funding for more expanded use of their product.
Show full opinionHide full opinion
Novelion (NVLN-T)
September 23, 2003
One trick pony however, they do have some tremendous potential for expansion of their Visodine product. Also expecting approval for funding for more expanded use of their product.
DON'T BUY
DON'T BUY
September 19, 2003
Has a very difficult time breaking the $24 mark. Has had a lot of good news. Does not look cheap on earnings basis. Could still have failure at the FDA trials. Risky.
Show full opinionHide full opinion
Novelion (NVLN-T)
September 19, 2003
Has a very difficult time breaking the $24 mark. Has had a lot of good news. Does not look cheap on earnings basis. Could still have failure at the FDA trials. Risky.
PAST TOP PICK
PAST TOP PICK
September 18, 2003
(A top pick Aug 6/03. Up 3%.) Still likes.
Show full opinionHide full opinion
Novelion (NVLN-T)
September 18, 2003
(A top pick Aug 6/03. Up 3%.) Still likes.
BUY
BUY
September 17, 2003
OK to buy the long-term. Should be a terrific performer in the next 2/3 years.
Show full opinionHide full opinion
Novelion (NVLN-T)
September 17, 2003
OK to buy the long-term. Should be a terrific performer in the next 2/3 years.
BUY WEAKNESS
BUY WEAKNESS
August 19, 2003
A news driven stock.This sector is volatile, but this company has product and makes money.A pretty good company, but buy on the dips.
Show full opinionHide full opinion
Novelion (NVLN-T)
August 19, 2003
A news driven stock.This sector is volatile, but this company has product and makes money.A pretty good company, but buy on the dips.
BUY
BUY
August 19, 2003
Should be able to move higher.Earnings should continue to grow.Could be a takeover.
Show full opinionHide full opinion
Novelion (NVLN-T)
August 19, 2003
Should be able to move higher.Earnings should continue to grow.Could be a takeover.
DON'T BUY
DON'T BUY
August 18, 2003
It has demographics going for it.Visodine sales are ramping up a little.The easy money has been made.Starting to look a little bit expensive.
Show full opinionHide full opinion
Novelion (NVLN-T)
August 18, 2003
It has demographics going for it.Visodine sales are ramping up a little.The easy money has been made.Starting to look a little bit expensive.
BUY
BUY
August 15, 2003
Believes there are several catalysts in the next few months that potentially could make the shares move to a price level that would be higher than merited by their existing business.
Show full opinionHide full opinion
Novelion (NVLN-T)
August 15, 2003
Believes there are several catalysts in the next few months that potentially could make the shares move to a price level that would be higher than merited by their existing business.
BUY WEAKNESS
BUY WEAKNESS
August 11, 2003
Had a good run.Would like to buy it a dollar or two cheaper.
Show full opinionHide full opinion
Novelion (NVLN-T)
August 11, 2003
Had a good run.Would like to buy it a dollar or two cheaper.
TOP PICK
TOP PICK
August 6, 2003
They are finding more and more uses for their product.Could be used in cancer treatment.World-class technology.
Show full opinionHide full opinion
Novelion (NVLN-T)
August 6, 2003
They are finding more and more uses for their product.Could be used in cancer treatment.World-class technology.
WEAK BUY
WEAK BUY
July 28, 2003
Looking better. Fundamentals are good. Profitable.
Show full opinionHide full opinion
Novelion (NVLN-T)
July 28, 2003
Looking better. Fundamentals are good. Profitable.
BUY WEAKNESS
BUY WEAKNESS
July 21, 2003
Nice base pattern. Could be a little higher a year from now.
Show full opinionHide full opinion
Novelion (NVLN-T)
July 21, 2003
Nice base pattern. Could be a little higher a year from now.
BUY
BUY
June 19, 2003
Still has some good upside potential.
Show full opinionHide full opinion
Novelion (NVLN-T)
June 19, 2003
Still has some good upside potential.
BUY WEAKNESS
BUY WEAKNESS
June 10, 2003
Was extremely cheap in the $11/12 range, but feels $17/18 may be a little high. Would like to see a pull back.
Show full opinionHide full opinion
Novelion (NVLN-T)
June 10, 2003
Was extremely cheap in the $11/12 range, but feels $17/18 may be a little high. Would like to see a pull back.
BUY
BUY
June 10, 2003
Great product. Should be able to expand its one product or will be taken over. Good shape financially.
Show full opinionHide full opinion
Novelion (NVLN-T)
June 10, 2003
Great product. Should be able to expand its one product or will be taken over. Good shape financially.
Showing 61 to 75 of 190 entries